PrecisionLife licenses OXEGENE dataset to develop personalized treatments for endometriosis

FHS
July 10, 2023
6:01 am

PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the University of Oxford to license the Oxford Endometriosis Gene (OXEGENE) dataset with the aim to develop new personalised treatments for endometriosis patients.

Global health burden of neurological conditions is much greater than previously understood, study reveals

Globally, the number of people living with, or dying from, neurological conditions such as stroke, Alzheimer’s disease and other dementias, and meningitis has risen substantially

March 18, 2024

Maternal Obesity Linked to Sudden Unexpected Infant Death

Babies born to mothers with obesity had a higher risk of sudden unexpected infant death (SUID) compared with those born to moms with normal body

July 30, 2024

FDA questions off-target edit testing on Vertex and CRISPR’s potential sickle cell gene therapy ahead of adcomm

The FDA is convening an advisory committee next Tuesday to discuss whether Vertex Pharmaceuticals and CRISPR Therapeutics did enough to adequately measure the off-target alterations

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.